Skoči na glavni sadržaj

Izvorni znanstveni članak

The evaluation of risk for obstructive sleep apnea in patients with type 2 diabetes

Vanesa Zemunik ; Sveučilišni odjel zdravstvenih studija Sveučilišta u Splitu, Preddiplomski sveučilišni studijski program sestrinstva
Ivana Pavlinac Dodig ; Centar za medicinu spavanja Medicinskog fakulteta u Splitu i KBC-a Split, Zavod za neuroznanost Medicinskog fakulteta u Splitu
Maja Valić ; Centar za medicinu spavanja Medicinskog fakulteta u Splitu i KBC-a Split, Zavod za neuroznanost Medicinskog fakulteta u Splitu
Tina Tičinović Kurir ; Regionalni centar za dijabetes, endokrinologiju i bolesti metabolizma, KBC Split
Zoran Đogaš orcid id orcid.org/0000-0003-3138-3887 ; Centar za medicinu spavanja Medicinskog fakulteta u Splitu i Kliničkog bolničkog centra Split, Zavod za neuroznanost Medicinskog fakulteta u Splitu
Renata Pecotić orcid id orcid.org/0000-0003-3519-2201 ; Centar za medicinu spavanja Medicinskog fakulteta u Splitu i KBC-a Split, Zavod za neuroznanost Medicinskog fakulteta u Splitu


Puni tekst: hrvatski pdf 268 Kb

str. 179-187

preuzimanja: 1.688

citiraj


Sažetak

The aim of this study was to evaluate the risk for obstructive sleep apnea (OSA) in patients with type 2 diabetes using the STOP questionnaire (Snoring, Tiredness, Observed, Pressure; STOP). Excessive daytime sleepiness was evaluated with the Epworth sleepiness scale (ESS). Previous studies support the idea that
glucose intolerance and type 2 diabetes might represent risk factors for OSA, as well as the idea of OSA being the risk factor for type 2 diabetes. A total of 252 patients with type 2 diabetes were surveyed during the regular follow-up in the Regional Centre for Diabetes, Endocrinology and Metabolic Diseases of Split University Hospital. The results of our study indicate that 156 patients (61.9%) had increased risk for OSA according to STOP questionnaire score. In addition, those at high risk for OSA were older (65 vs. 61 years
of age, p < 0.05), had higher body mass index (BMI, 28.6 ± 5.1 vs. 26.5 ± 4.1, p < 0.001), higher neck circumference (41.5 ± 4.7 vs. 39.6 ± 6.2, p < 0.009), and had excessive daytime sleepiness according to the ESS score (5.3 ± 3.1 vs. 3.9 ± 2.5, p < 0.001). Individuals with type 2 diabetes reported to have comorbidities, mainly hypertension (46%), gastroesophageal reflux disease (28%), depression (10%), and asthma (8%). Based on current evidence from literature, OSA could be related to clinical conditions such as
diabetes and essential hypertension. More epidemiological data are needed to establish the prevalence of OSA in Croatian patients with type 2 diabetes. Our findings indicate the relevance of STOP questionnaire use as a screening tool for obstructive sleep apnea in patients with type 2 diabetes in Croatia.

Ključne riječi

obstructive sleep apnea-screening tools; type 2 diabetes; questionnaires-STOP; Epworth sleepiness scale

Hrčak ID:

113348

URI

https://hrcak.srce.hr/113348

Datum izdavanja:

13.1.2014.

Podaci na drugim jezicima: hrvatski

Posjeta: 3.258 *